Abstract

Serous borderline tumor (SBT) represents a group of noninvasive tumor of ovary bridging between benign adenoma and invasive carcinoma. They are commonly seen in younger women and have excellent outcome, except occasional local recurrence. Metastasis to the lymph nodes has rarely occurred. So far, the only distant metastases reported were to the supraclavicular and internal mammary lymph node. Here, we present a 33-year-old nulliparous woman diagnosed with Stage IV-B serous borderline tumor to the brain. Her serous borderline tumor with 1 mm focus of microstromal invasion of left ovary eight years ago, with a recurrent tumor of the right ovary occurred 4 years ago, for which she underwent two unilateral salpingo-oophorectomies with omentectomy on separate occasions with extensive abdominal, peritoneal, and pelvic lymph node biopsies. No evidence of extraovarian spread on both times was identified. However, 4 years after her last surgery, the patient presented to our institution with a migraine. MRI revealed four supratentorial lesions with two dominant proteinaceous mass lesions (6.0 x 4.5 x 3.5 cm and 4.5 x 3.5 x 2.8 cm) having irregular lobulations in the bilateral temporal lobes consistent with metastatic disease. Biopsy of the dominant lesion shows clusters of broad papillae with hierarchical branching lined by polygonal to columnar serous epithelium with mild to moderate atypia. Findings are consistent with metastatic serous borderline tumor. To our best knowledge, this is the first case reported of a serous borderline tumor with metastasis to the brain. No current review or literature supports this distant metastasis.

Highlights

  • BackgroundSerous borderline tumor represents a group of noninvasive tumor of the ovary bridging between benign serous cystadenoma and serous carcinoma

  • 3000 American women are diagnosed with borderline ovarian tumors (BOTs) annually and account for 15–20% of all ovarian epithelial tumors

  • They are known as a tumor of low malignant potential (LMP) or as an atypical proliferative tumor

Read more

Summary

Background

Serous borderline tumor represents a group of noninvasive tumor of the ovary bridging between benign serous cystadenoma and serous carcinoma. They are commonly seen in younger women and usually have an excellent outcome but seldom show local recurrence Metastasis to the lymph nodes has rarely been reported The brain is exceptionally a rare metastatic site for ovarian tumor. There is one case of an advanced staged SBT with micropapillary pattern metastasis to the brain recently and by far it is the most distant metastasis reported To the best of our knowledge, no report has been documented for a recurrent stage 1 typical SBT metastasizing to the brain

Introduction
Case Report
Discussion
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.